Xellia Pharmaceuticals

Phone: +86 57-688827026

Fax: +86 57-688827023

Web: https://www.xellia.com/

Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Xellia is wholly owned by Novo Holdings A/S since 2013 and headquartered in Copenhagen, Denmark. We have five state-of-the-art manufacturing facilities located in; Denmark, Hungary, China and in the U.S.

For detailed contact information visit location pages below.